Recruiting
Phase 2

Ramucirumab & Paclitaxel

Sponsor:

SWOG Cancer Research Network

Code:

NCT04205968

Conditions

Metastatic Small Intestinal Adenocarcinoma

Stage III Small Intestinal Adenocarcinoma AJCC v8

Stage IIIA Small Intestinal Adenocarcinoma AJCC v8

Stage IIIB Small Intestinal Adenocarcinoma AJCC v8

Stage IV Small Intestinal Adenocarcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fluorouracil

Irinotecan

Irinotecan Hydrochloride

Leucovorin

Leucovorin Calcium

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information